Australia markets close in 55 minutes

Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
2.3600-0.0700 (-2.88%)
As of 01:02PM CST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
45,258,325
49,698,874
49,615,695
49,583,191
41,200,411
-
Cost of revenue
25,643,416
9,829,634
8,458,558
7,311,617
3,225,146
-
Gross profit
19,614,910
39,869,240
41,157,137
42,271,573
37,975,264
-
Operating expenses
Research development
-
-
-
-
0
5,662
Selling general and administrative
429,389
473,699
333,971
541,056
628,195
-
Total operating expenses
7,535,339
18,159,560
10,159,505
10,437,885
34,399,123
-
Operating income or loss
12,079,570
21,709,680
30,997,632
31,833,689
3,576,141
-
Income before tax
-2,145,071
-1,868,003
224,778
343,123
1,449,461
-
Income tax expense
-606,628
-586,505
-285,842
-537,095
331,556
-
Income from continuing operations
-1,538,443
-1,281,499
510,620
880,218
1,117,906
-
Net income
-786,840
-651,759
274,051
470,714
580,292
-
Net income available to common shareholders
-786,840
-651,759
274,051
470,714
580,292
-
Basic EPS
-0.03
-0.13
0.06
0.10
0.12
-
Diluted EPS
-0.03
-0.13
0.06
0.10
0.12
-
Basic average shares
4,568,938
5,013,527
4,567,519
4,707,137
4,835,769
-
Diluted average shares
4,568,938
5,013,527
4,567,519
4,707,137
4,835,769
-